Kang YM, Giugliano RP, Ran X, Deedwania P, et al. Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial. Diabetes Care 2025 Jun 22:dc250942. doi: 10.2337/dc25-0942.
PMID: 40544474